| scholarly article | Q13442814 |
| P50 | author | Yong-Sung Kim | Q40568330 |
| P2093 | author name string | Jeong-Sun Kim | |
| Ji-Young Jang | |||
| Myung-Hee Kwon | |||
| Woo-Ram Lee | |||
| P2860 | cites work | Zinc Finger Tools: custom DNA-binding domains for transcription factors and nucleases | Q24680179 |
| Tumour prevention by a single antibody domain targeting the interaction of signal transduction proteins with RAS | Q27645826 | ||
| Synthetic antibodies for specific recognition and crystallization of structured RNA | Q27649448 | ||
| Crystal structure of single-domain VL of an anti-DNA binding antibody 3D8 scFv and its active site revealed by complex structures of a small molecule and metals | Q27650071 | ||
| Origins and Mechanisms of miRNAs and siRNAs | Q27860822 | ||
| Cytotoxic ribonucleases: molecular weapons and their targets | Q28189322 | ||
| Polyreactive anti-DNA monoclonal antibodies and a derived peptide as vectors for the intracytoplasmic and intranuclear translocation of macromolecules | Q28379506 | ||
| A viral RNA competitively inhibits the antiviral endoribonuclease domain of RNase L | Q28754508 | ||
| Illuminating the silence: understanding the structure and function of small RNAs | Q29622905 | ||
| Construction and characterization of a pseudo-immune human antibody library using yeast surface display | Q33246866 | ||
| Protein i: interference at protein level by intrabodies | Q33264677 | ||
| Picomolar affinity fibronectin domains engineered utilizing loop length diversity, recursive mutagenesis, and loop shuffling | Q33349284 | ||
| Normalization of qRT-PCR data: the necessity of adopting a systematic, experimental conditions-specific, validation of references | Q33415275 | ||
| Fusion with an RNA binding domain to confer target RNA specificity to an RNase: design and engineering of Tat-RNase H that specifically recognizes and cleaves HIV-1 RNA in vitro | Q34595695 | ||
| RNA base-amino acid interaction strengths derived from structures and sequences | Q34631182 | ||
| Sequence-specific binding of single-stranded RNA: is there a code for recognition? | Q35128019 | ||
| Antibody penetration into living cells: pathogenic, preventive and immuno-therapeutic implications | Q35181501 | ||
| Approaches for the sequence-specific knockdown of mRNA. | Q35597089 | ||
| TransMabs: cell-penetrating antibodies, the next generation | Q36065969 | ||
| Destroying RNA as a therapeutic approach | Q36447193 | ||
| Creating a ribonuclease T-tat that preferentially recognizes and hydrolyzes HIV-1 TAR RNA in vitro and in vivo | Q36457182 | ||
| Enhancing and confirming the specificity of RNAi experiments | Q36575386 | ||
| Generation of sequence-specific, high affinity anti-DNA antibodies. | Q38302516 | ||
| A novel agonistic antibody to human death receptor 4 induces apoptotic cell death in various tumor cells without cytotoxicity in hepatocytes | Q39819752 | ||
| Recombinant immunoproapoptotic proteins with furin site can translocate and kill HER2-positive cancer cells | Q40033581 | ||
| Nuclear localizing anti-DNA antibodies enter cells via caveoli and modulate expression of caveolin and p53. | Q40435519 | ||
| Silencing of the HER2/neu gene by siRNA inhibits proliferation and induces apoptosis in HER2/neu-overexpressing breast cancer cells. | Q40456753 | ||
| Small interfering RNA (siRNA) inhibits the expression of the Her2/neu gene, upregulates HLA class I and induces apoptosis of Her2/neu positive tumor cell lines. | Q40616262 | ||
| Effects of solutes on solubilization and refolding of proteins from inclusion bodies with high hydrostatic pressure | Q41961798 | ||
| Structural modeling of sequence specificity by an autoantibody against single-stranded DNA. | Q42798676 | ||
| Generation of humanized anti-DNA hydrolyzing catalytic antibodies by complementarity determining region grafting | Q46298474 | ||
| A nucleic acid-hydrolyzing antibody penetrates into cells via caveolae-mediated endocytosis, localizes in the cytosol and exhibits cytotoxicity | Q47994013 | ||
| A human scFv antibody against TRAIL receptor 2 induces autophagic cell death in both TRAIL-sensitive and TRAIL-resistant cancer cells. | Q53565727 | ||
| A Comprehensive Model for the Cellular Uptake of Cationic Cell-penetrating Peptides | Q57374314 | ||
| Heavy and light chain variable single domains of an anti-DNA binding antibody hydrolyze both double- and single-stranded DNAs without sequence specificity | Q64388542 | ||
| Mechanisms of cellular penetration and nuclear localization of an anti-double strand DNA autoantibody | Q64389359 | ||
| Ribonuclease inhibitor from human placenta. Purification and properties | Q67012561 | ||
| DNA and heparin alter the internalization process of anti-DNA monoclonal antibodies according to patterns typical of both the charged molecule and the antibody | Q74136670 | ||
| Anti-DNA autoantibodies reveal toxicity to tumor cell lines | Q77209155 | ||
| Making cell-permeable antibodies (Transbody) through fusion of protein transduction domains (PTD) with single chain variable fragment (scFv) antibodies: potential advantages over antibodies expressed within the intracellular environment (Intrabody) | Q81638299 | ||
| Cell-penetrating anti-native DNA antibodies trigger apoptosis through both the neglect and programmed pathways | Q82038431 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | gene silencing | Q1431332 |
| antibody | Q79460 | ||
| P304 | page(s) | 1596-1609 | |
| P577 | publication date | 2009-12-09 | |
| P1433 | published in | Nucleic Acids Research | Q135122 |
| P1476 | title | Gene silencing by cell-penetrating, sequence-selective and nucleic-acid hydrolyzing antibodies | |
| P478 | volume | 38 |
| Q36213205 | A general strategy for generating intact, full-length IgG antibodies that penetrate into the cytosol of living cells |
| Q37593692 | Antibody light chain variable domains and their biophysically improved versions for human immunotherapy |
| Q39412526 | Antibody-Mediated Catalysis in Infection and Immunity |
| Q38197955 | Catalytic antibodies and their applications in biotechnology: state of the art. |
| Q51394112 | Cell-free production and streamlined assay of cytosol-penetrating antibodies. |
| Q28484366 | Cellular internalization mechanism and intracellular trafficking of filamentous M13 phages displaying a cell-penetrating transbody and TAT peptide |
| Q47307286 | Development of cell-penetrating bispecific antibodies targeting the N-terminal domain of androgen receptor for prostate cancer therapy. |
| Q51042734 | Effective capture of proteins inside living cells by antibodies indirectly linked to a novel cell-penetrating polymer-modified protein A derivative. |
| Q42732010 | IBC's 21st Annual Antibody Engineering and 8th Annual Antibody Therapeutics International Conferences and 2010 Annual Meeting of the Antibody Society. December 5-9, 2010, San Diego, CA USA. |
| Q36300378 | Single domain antibodies for the knockdown of cytosolic and nuclear proteins |
| Q50743140 | Variable Heavy Chain Domain Derived from a Cell-Penetrating Anti-DNA Monoclonal Antibody for the Intracellular Delivery of Biomolecules. |
Search more.